
USFDA APPLICATION NUMBER - 206619 / DOSAGE - TABLET;ORAL - EQ 250MG BASE;12.5MG, 75MG, 50MG
Inactive Ingredients
| Ingredient Name | AbbVie Inc. |
|---|---|
| COPOVIDONE K25-31(D9C330MD8B) | |
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| FERROSOFERRIC OXIDE(XM0M87F357) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| POLYETHYLENE GLYCOL 3350(G2M7P15E5P) | |
| POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |
| PROPYLENE GLYCOL LAURATES(40KT317HGP) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM STEARYL FUMARATE(7CV7WJK4UI) | |
| SORBITAN MONOLAURATE(6W9PS8B71J) | |
| TALC(7SEV7J4R1U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| TOCOPHERSOLAN(O03S90U1F2) |